ALIGOS THERAPEUTICS ($ALGS) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$3.41 per share, missing estimates of -$2.55 by $0.86. The company also reported revenue of $630,000, beating estimates of $441,996 by $188,004.
You can see Quiver Quantitative's $ALGS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALIGOS THERAPEUTICS Hedge Fund Activity
We have seen 1 institutional investors add shares of ALIGOS THERAPEUTICS stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AVIOR WEALTH MANAGEMENT, LLC added 80 shares (+inf%) to their portfolio in Q4 2024, for an estimated $3,187
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALIGOS THERAPEUTICS Government Contracts
We have seen $1,300,776 of award payments to $ALGS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
